October 22, 2010
Bayer Animal Health piglet vaccine receives market authorisation
Bayer HealthCare, Animal Health has received market authorisation for BaycoxÂ® 5% (a 5% suspension of toltrazuril) for use in piglets, which is now available in Canada.
BaycoxÂ® 5% is indicated for the treatment of preclinical coccidiosis due to Isospora suis in neonatal piglets.
Dr. Bruce Kilmer, Bayer HealthCare, Animal Health's Director of Technical Services & Regulatory Affairs, understands the far reaching benefits swine producers can enjoy from improved piglet gut health.
Dr. Mike Sheridan, a Manitoba swine veterinarian welcomes BaycoxÂ® 5%, "It's great to have a product like this as it allows me to offer my producers an effective treatment option for improved gut health."